← Open Payments lookup

KYLE DIETZ: Open Payments

NPI 1922607670 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,258 in 55 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $319 · 2025 $1,258

Food & beverage: $1,258
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$286
Vanda Pharmaceuticals Inc.7$176
Otsuka America Pharmaceutical, Inc.12$168
Alkermes, Inc.5$128
ABBVIE INC.5$116
Tris Pharma Inc3$68
Collegium Pharmaceutical, Inc.4$66
Takeda Pharmaceuticals U.S.A., Inc.2$51
E.R. Squibb & Sons, L.L.C.2$37
Teva Pharmaceuticals USA, Inc.2$34

Products named: CAPLYTA, FANAPT, REXULTI, VRAYLAR, ARISTADA, Dyanavel XR, Jornay PM, TRINTELLIX.

Industry payments across CO — which companies pay providers there.